[go: up one dir, main page]

TN2009000211A1 - Antiviral composition and method of use - Google Patents

Antiviral composition and method of use

Info

Publication number
TN2009000211A1
TN2009000211A1 TNP2009000211A TN2009000211A TN2009000211A1 TN 2009000211 A1 TN2009000211 A1 TN 2009000211A1 TN P2009000211 A TNP2009000211 A TN P2009000211A TN 2009000211 A TN2009000211 A TN 2009000211A TN 2009000211 A1 TN2009000211 A1 TN 2009000211A1
Authority
TN
Tunisia
Prior art keywords
antiviral composition
lambdacarrageenan
iota
kappa
prophylaxis
Prior art date
Application number
TNP2009000211A
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Christiane Meier
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06450176A external-priority patent/EP1930015A1/fr
Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of TN2009000211A1 publication Critical patent/TN2009000211A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paper (AREA)
TNP2009000211A 2006-12-05 2009-05-29 Antiviral composition and method of use TN2009000211A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06450176A EP1930015A1 (fr) 2006-12-05 2006-12-05 Utilisation de carraghénine pour traiter les infections causées par le rhinovirus
US11/567,078 US20080131454A1 (en) 2006-12-05 2006-12-05 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
PCT/EP2007/010512 WO2008067982A2 (fr) 2006-12-05 2007-12-04 Composition antivirale et procédé d'utilisation

Publications (1)

Publication Number Publication Date
TN2009000211A1 true TN2009000211A1 (en) 2010-10-18

Family

ID=39383268

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000211A TN2009000211A1 (en) 2006-12-05 2009-05-29 Antiviral composition and method of use

Country Status (23)

Country Link
EP (1) EP2101792B1 (fr)
JP (1) JP5470047B2 (fr)
KR (1) KR101437708B1 (fr)
CN (1) CN101678040B (fr)
AT (1) ATE462438T1 (fr)
AU (1) AU2007327934B2 (fr)
BR (1) BRPI0720054A2 (fr)
CA (1) CA2671317C (fr)
CY (1) CY1110658T1 (fr)
DE (1) DE602007005697D1 (fr)
DK (1) DK2101792T3 (fr)
EA (1) EA015930B1 (fr)
ES (1) ES2343701T3 (fr)
IL (1) IL198810A (fr)
MA (1) MA31145B1 (fr)
MX (1) MX2009005838A (fr)
NO (1) NO342681B1 (fr)
NZ (1) NZ577063A (fr)
PL (1) PL2101792T3 (fr)
PT (1) PT2101792E (fr)
SI (1) SI2101792T1 (fr)
TN (1) TN2009000211A1 (fr)
WO (1) WO2008067982A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2303287E (pt) * 2008-07-01 2014-02-27 Marinomed Biotechnologie Gmbh Biopolímeros antialérgicos marinhos
JP5702526B2 (ja) 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
SG181421A1 (en) 2009-12-22 2012-07-30 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
JP5900030B2 (ja) 2011-03-08 2016-04-06 凸版印刷株式会社 防湿容器
ES2734269T3 (es) * 2014-01-22 2019-12-05 Visufarma B V Composición que comprende carragenina tipo iota contra conjuntivitis viral
DK3370692T3 (da) 2015-07-14 2023-06-26 Marinomed Biotech Ag Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet
UA118192C2 (uk) * 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en) 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN111437270A (zh) * 2020-04-24 2020-07-24 瑞希(重庆)生物科技有限公司 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
US12280142B2 (en) 2020-09-08 2025-04-22 Altamira Medica AG Compositions for preventing infection
KR102720037B1 (ko) * 2021-12-21 2024-10-22 (주)메디코어 비강 세정제 조성물 및 그 제조방법
WO2025067689A1 (fr) 2023-09-26 2025-04-03 Metriopharm Ag 5-amino-2,3-dihydro-1,4-phtalazinedione pour le traitement d'infections par un virus à arn
WO2025114567A1 (fr) * 2023-11-30 2025-06-05 Université De Strasbourg Biomatériau à propriétés antibactériennes et antivirales simultanées

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60119534T2 (de) 2000-07-28 2007-05-10 Immupharm Aps Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
US6953483B2 (en) * 2002-03-05 2005-10-11 Litke Kenneth S Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
WO2003093322A2 (fr) * 2002-04-30 2003-11-13 The Population Council, Inc. Formulations ameliorees de polysaccharide sulfate, leurs procedes, preparations et utilisations
CN1194981C (zh) * 2002-07-22 2005-03-30 青岛海洋大学 卡拉胶低聚糖的制备方法
CN101385740B (zh) * 2003-05-26 2011-06-08 福州大学 多糖硫酸酯作为制备抗流感病毒药物的应用
WO2005004882A1 (fr) * 2003-07-09 2005-01-20 Monash University Polymeres charges antiviraux presentant une resistance a la degradation lysosomale pendant une filtration renale et un passage renal, compositions et methodes d'utilisation correspondantes
US20080004236A1 (en) * 2004-02-06 2008-01-03 Comper Wayne D High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
DE202005014019U1 (de) * 2005-09-05 2005-11-24 G. Pohl-Boskamp Gmbh & Co. Kg Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) * 2006-03-06 2006-06-05 Paolo Ottier Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de) 2006-07-07 2008-01-17 Leoni Ag Sensorsystem und Sensorelement

Also Published As

Publication number Publication date
CA2671317C (fr) 2015-03-17
IL198810A0 (en) 2010-02-17
JP5470047B2 (ja) 2014-04-16
EP2101792A2 (fr) 2009-09-23
WO2008067982A3 (fr) 2009-04-16
MA31145B1 (fr) 2010-02-01
CA2671317A1 (fr) 2008-06-12
WO2008067982A2 (fr) 2008-06-12
EP2101792B1 (fr) 2010-03-31
PT2101792E (pt) 2010-06-25
JP2010512307A (ja) 2010-04-22
DE602007005697D1 (de) 2010-05-12
NO20091955L (no) 2009-09-04
NO342681B1 (no) 2018-07-02
EA200970529A1 (ru) 2009-12-30
IL198810A (en) 2013-03-24
CY1110658T1 (el) 2015-06-10
ES2343701T3 (es) 2010-08-06
KR20090096598A (ko) 2009-09-11
AU2007327934A1 (en) 2008-06-12
HK1141980A1 (en) 2010-11-26
SI2101792T1 (sl) 2010-08-31
AU2007327934B2 (en) 2013-04-18
KR101437708B1 (ko) 2014-09-03
CN101678040B (zh) 2012-10-03
ATE462438T1 (de) 2010-04-15
DK2101792T3 (da) 2010-07-26
MX2009005838A (es) 2009-06-16
BRPI0720054A2 (pt) 2013-12-17
PL2101792T3 (pl) 2010-11-30
NZ577063A (en) 2011-05-27
CN101678040A (zh) 2010-03-24
EA015930B1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
IL198810A0 (en) Antiviral composition and method of use
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
EP2099449A4 (fr) Composition pharmaceutique pour le traitement et la prévention d'affection impliquant l'impuissance
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
TNSN08400A1 (en) Organic compounds and their uses
UA98299C2 (ru) Новая лекарственная форма рацекадотрила
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
IL202351A (en) (2 – oxo – 1,3 – oxazolidine – 5 – ile)
SG152237A1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
TNSN08496A1 (en) Aminothiazoles and their uses
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
JO2730B1 (en) Medications for the treatment of endometriosis
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
ATE380188T1 (de) Substituierte chinolone
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
UA88655C2 (ru) S-миртазапин для лечения прилива крови
WO2006089664A3 (fr) Imidazoles substitues par heterocyclylamide
WO2008157365A3 (fr) Procédés ou utilisations et compositions pour traiter ou empêcher la douleur neuropathique
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
MY166063A (en) Intravenous antiviral treatments